Blockade of Hedgehog Signaling Synergistically Increases Sensitivity to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Cell Lines.
Aberrant activation of the hedgehog (Hh) signaling pathway has been implicated in the epithelial-to-mesenchymal transition (EMT) and cancer stem-like cell (CSC) maintenance; both processes can result in tumor progression and treatment resistance in several types of human cancer. Hh cooperates with t...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4778934?pdf=render |
id |
doaj-6bd7ab1b9fac4b9b9af988acec6a93d0 |
---|---|
record_format |
Article |
spelling |
doaj-6bd7ab1b9fac4b9b9af988acec6a93d02020-11-24T21:23:17ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01113e014937010.1371/journal.pone.0149370Blockade of Hedgehog Signaling Synergistically Increases Sensitivity to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Cell Lines.Xiao-Yan BaiXu-Chao ZhangSu-Qing YangShe-Juan AnZhi-Hong ChenJian SuZhi XieLan-Ying GouYi-Long WuAberrant activation of the hedgehog (Hh) signaling pathway has been implicated in the epithelial-to-mesenchymal transition (EMT) and cancer stem-like cell (CSC) maintenance; both processes can result in tumor progression and treatment resistance in several types of human cancer. Hh cooperates with the epidermal growth factor receptor (EGFR) signaling pathway in embryogenesis. We found that the Hh signaling pathway was silenced in EGFR-TKI-sensitive non-small-cell lung cancer (NSCLC) cells, while it was inappropriately activated in EGFR-TKI-resistant NSCLC cells, accompanied by EMT induction and ABCG2 overexpression. Upregulation of Hh signaling through extrinsic SHH exposure downregulated E-cadherin expression and elevated Snail and ABCG2 expression, resulting in gefitinib tolerance (P < 0.001) in EGFR-TKI-sensitive cells. Blockade of the Hh signaling pathway using the SMO antagonist SANT-1 restored E-cadherin expression and downregulate Snail and ABCG2 in EGFR-TKI-resistant cells. A combination of SANT-1 and gefitinib markedly inhibited tumorigenesis and proliferation in EGFR-TKI-resistant cells (P < 0.001). These findings indicate that hyperactivity of Hh signaling resulted in EGFR-TKI resistance, by EMT introduction and ABCG2 upregulation, and blockade of Hh signaling synergistically increased sensitivity to EGFR-TKIs in primary and secondary resistant NSCLC cells. E-cadherin expression may be a potential biomarker of the suitability of the combined application of an Hh inhibitor and EGFR-TKIs in EGFR-TKI-resistant NSCLCs.http://europepmc.org/articles/PMC4778934?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Xiao-Yan Bai Xu-Chao Zhang Su-Qing Yang She-Juan An Zhi-Hong Chen Jian Su Zhi Xie Lan-Ying Gou Yi-Long Wu |
spellingShingle |
Xiao-Yan Bai Xu-Chao Zhang Su-Qing Yang She-Juan An Zhi-Hong Chen Jian Su Zhi Xie Lan-Ying Gou Yi-Long Wu Blockade of Hedgehog Signaling Synergistically Increases Sensitivity to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Cell Lines. PLoS ONE |
author_facet |
Xiao-Yan Bai Xu-Chao Zhang Su-Qing Yang She-Juan An Zhi-Hong Chen Jian Su Zhi Xie Lan-Ying Gou Yi-Long Wu |
author_sort |
Xiao-Yan Bai |
title |
Blockade of Hedgehog Signaling Synergistically Increases Sensitivity to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Cell Lines. |
title_short |
Blockade of Hedgehog Signaling Synergistically Increases Sensitivity to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Cell Lines. |
title_full |
Blockade of Hedgehog Signaling Synergistically Increases Sensitivity to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Cell Lines. |
title_fullStr |
Blockade of Hedgehog Signaling Synergistically Increases Sensitivity to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Cell Lines. |
title_full_unstemmed |
Blockade of Hedgehog Signaling Synergistically Increases Sensitivity to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Cell Lines. |
title_sort |
blockade of hedgehog signaling synergistically increases sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer cell lines. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2016-01-01 |
description |
Aberrant activation of the hedgehog (Hh) signaling pathway has been implicated in the epithelial-to-mesenchymal transition (EMT) and cancer stem-like cell (CSC) maintenance; both processes can result in tumor progression and treatment resistance in several types of human cancer. Hh cooperates with the epidermal growth factor receptor (EGFR) signaling pathway in embryogenesis. We found that the Hh signaling pathway was silenced in EGFR-TKI-sensitive non-small-cell lung cancer (NSCLC) cells, while it was inappropriately activated in EGFR-TKI-resistant NSCLC cells, accompanied by EMT induction and ABCG2 overexpression. Upregulation of Hh signaling through extrinsic SHH exposure downregulated E-cadherin expression and elevated Snail and ABCG2 expression, resulting in gefitinib tolerance (P < 0.001) in EGFR-TKI-sensitive cells. Blockade of the Hh signaling pathway using the SMO antagonist SANT-1 restored E-cadherin expression and downregulate Snail and ABCG2 in EGFR-TKI-resistant cells. A combination of SANT-1 and gefitinib markedly inhibited tumorigenesis and proliferation in EGFR-TKI-resistant cells (P < 0.001). These findings indicate that hyperactivity of Hh signaling resulted in EGFR-TKI resistance, by EMT introduction and ABCG2 upregulation, and blockade of Hh signaling synergistically increased sensitivity to EGFR-TKIs in primary and secondary resistant NSCLC cells. E-cadherin expression may be a potential biomarker of the suitability of the combined application of an Hh inhibitor and EGFR-TKIs in EGFR-TKI-resistant NSCLCs. |
url |
http://europepmc.org/articles/PMC4778934?pdf=render |
work_keys_str_mv |
AT xiaoyanbai blockadeofhedgehogsignalingsynergisticallyincreasessensitivitytoepidermalgrowthfactorreceptortyrosinekinaseinhibitorsinnonsmallcelllungcancercelllines AT xuchaozhang blockadeofhedgehogsignalingsynergisticallyincreasessensitivitytoepidermalgrowthfactorreceptortyrosinekinaseinhibitorsinnonsmallcelllungcancercelllines AT suqingyang blockadeofhedgehogsignalingsynergisticallyincreasessensitivitytoepidermalgrowthfactorreceptortyrosinekinaseinhibitorsinnonsmallcelllungcancercelllines AT shejuanan blockadeofhedgehogsignalingsynergisticallyincreasessensitivitytoepidermalgrowthfactorreceptortyrosinekinaseinhibitorsinnonsmallcelllungcancercelllines AT zhihongchen blockadeofhedgehogsignalingsynergisticallyincreasessensitivitytoepidermalgrowthfactorreceptortyrosinekinaseinhibitorsinnonsmallcelllungcancercelllines AT jiansu blockadeofhedgehogsignalingsynergisticallyincreasessensitivitytoepidermalgrowthfactorreceptortyrosinekinaseinhibitorsinnonsmallcelllungcancercelllines AT zhixie blockadeofhedgehogsignalingsynergisticallyincreasessensitivitytoepidermalgrowthfactorreceptortyrosinekinaseinhibitorsinnonsmallcelllungcancercelllines AT lanyinggou blockadeofhedgehogsignalingsynergisticallyincreasessensitivitytoepidermalgrowthfactorreceptortyrosinekinaseinhibitorsinnonsmallcelllungcancercelllines AT yilongwu blockadeofhedgehogsignalingsynergisticallyincreasessensitivitytoepidermalgrowthfactorreceptortyrosinekinaseinhibitorsinnonsmallcelllungcancercelllines |
_version_ |
1725992483788161024 |